Jci_page_head_homepage_01 Jci_page_head_homepage_02
Andrea Kristina Horst, Wulf D. Ito, Joachim Dabelstein, Udo Schumacher, Heike Sander, Claire Turbide, Jens Brümmer, Thomas Meinertz, Nicole Beauchemin, Christoph Wagener
Published in Volume 116, Issue 6
J Clin Invest. 2006; 116(6):1596–1605 doi:10.1172/JCI24340
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1
Effects of CEACAM1 expression on the murine endothelial cell line SVEC4-10.

(A) Two-dimensional Matrigel transwell assay with different CEACAM1-infected SVEC4-10 clones. After retrovirally mediated infections, 3 clones per CEACAM1 mutant were selected and subjected to a transmigration assay with NIH3T3 fibroblast–conditioned medium as a chemoattractant in the bottom chamber. All assays were carried out in triplicate, and the number of migrated cells was averaged. UT, untransfected SVEC4-10 cells; neo, mock-infected. (B) Three-dimensional fibrin assay with CEACAM1-infected SVEC4-10 cells. SVEC4-10 cells expressing different forms of CEACAM1-L were grown in a 3-dimensional fibrin matrix for 3 days, and endothelial cell protrusions were documented. Experiments were carried out in triplicate with 3 different clones per mutant. Representative images of 1 clone are shown. Magnification, ×200.